SUPERVALU Inc. (SVU) Reaches $15.31 After 3.00% Down Move; Hologic (HOLX) Sentiment Is 0.74

April 16, 2018 - By Hazel Jackson

Hologic, Inc. (NASDAQ:HOLX) Logo

The stock of SUPERVALU Inc. (NYSE:SVU) is a huge mover today! The stock decreased 2.42% or $0.38 during the last trading session, reaching $15.31. About 671,707 shares traded. SUPERVALU Inc. (NYSE:SVU) has declined 43.42% since April 16, 2017 and is downtrending. It has underperformed by 54.97% the S&P500.The move comes after 8 months negative chart setup for the $588.04 million company. It was reported on Apr, 16 by Barchart.com. We have $14.85 PT which if reached, will make NYSE:SVU worth $17.64 million less.

Hologic Inc (HOLX) investors sentiment decreased to 0.74 in 2017 Q4. It’s down -0.14, from 0.88 in 2017Q3. The ratio dived, as 164 investment managers started new or increased positions, while 222 cut down and sold their stakes in Hologic Inc. The investment managers in our database now hold: 264.36 million shares, down from 265.54 million shares in 2017Q3. Also, the number of investment managers holding Hologic Inc in top ten positions increased from 2 to 3 for an increase of 1. Sold All: 57 Reduced: 165 Increased: 94 New Position: 70.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company has market cap of $10.40 billion. It operates through four divisions: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It has a 9.95 P/E ratio. The Diagnostics segment provides Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, Procleix family of assays for blood screening, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test.

Ratings analysis reveals 80% of Hologic’s analysts are positive. Out of 5 Wall Street analysts rating Hologic, 4 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $44.0 while the high is $48.0. The stock’s average target of $46 is 22.34% above today’s ($37.6) share price. HOLX was included in 5 notes of analysts from September 23, 2016. The firm has “Neutral” rating by Bank of America given on Wednesday, February 15. The stock has “Buy” rating by Needham on Wednesday, February 15. Piper Jaffray upgraded Hologic, Inc. (NASDAQ:HOLX) on Wednesday, January 4 to “Overweight” rating. The firm earned “Overweight” rating on Friday, September 23 by Barclays Capital. The stock of Hologic, Inc. (NASDAQ:HOLX) earned “Buy” rating by Deutsche Bank on Wednesday, January 18.

Waterstone Capital Management L.P. holds 13.89% of its portfolio in Hologic, Inc. for 446,800 shares. Domini Impact Investments Llc owns 5,877 shares or 5.14% of their US portfolio. Moreover, Kahn Brothers Group Inc De has 4.64% invested in the company for 691,667 shares. The New York-based American Capital Management Inc has invested 3% in the stock. Endurant Capital Management Lp, a California-based fund reported 222,844 shares.

Since January 1, 0001, it had 3 insider purchases, and 1 sale for $682,999 activity.

Analysts await Hologic, Inc. (NASDAQ:HOLX) to report earnings on May, 9. They expect $0.53 EPS, up 6.00% or $0.03 from last year’s $0.5 per share. HOLX’s profit will be $146.55 million for 17.74 P/E if the $0.53 EPS becomes a reality. After $0.55 actual EPS reported by Hologic, Inc. for the previous quarter, Wall Street now forecasts -3.64% negative EPS growth.

The stock increased 1.57% or $0.58 during the last trading session, reaching $37.6. About 451,562 shares traded. Hologic, Inc. (HOLX) has declined 11.91% since April 16, 2017 and is downtrending. It has underperformed by 23.46% the S&P500.

Among 9 analysts covering Supervalu Inc. (NYSE:SVU), 3 have Buy rating, 1 Sell and 5 Hold. Therefore 33% are positive. Supervalu Inc. had 30 analyst reports since July 24, 2015 according to SRatingsIntel. Telsey Advisory Group maintained the stock with “Market Perform” rating in Tuesday, June 27 report. Telsey Advisory Group maintained the stock with “Market Perform” rating in Friday, September 9 report. Northcoast downgraded the stock to “Neutral” rating in Thursday, October 19 report. RBC Capital Markets maintained SUPERVALU Inc. (NYSE:SVU) on Friday, September 9 with “Sector Perform” rating. RBC Capital Markets upgraded it to “Outperform” rating and $6 target in Thursday, March 23 report. The stock of SUPERVALU Inc. (NYSE:SVU) earned “Outperform” rating by Telsey Advisory Group on Wednesday, July 29. The company was maintained on Thursday, October 19 by Morgan Stanley. The stock of SUPERVALU Inc. (NYSE:SVU) earned “Outperform” rating by Telsey Advisory Group on Friday, January 8. The stock has “Equal Weight” rating by Morgan Stanley on Wednesday, July 29. RBC Capital Markets maintained the shares of SVU in report on Friday, July 14 with “Buy” rating.

Investors sentiment increased to 1 in Q4 2017. Its up 1.00, from 0 in 2017Q3. It increased, as 2 investors sold SUPERVALU Inc. shares while 0 reduced holdings. 1 funds opened positions while 1 raised stakes. 39,406 shares or 52.76% less from 83,422 shares in 2017Q3 were reported. Greenwich Wealth Mngmt Limited Com, a Connecticut-based fund reported 39,265 shares. Gemmer Asset Ltd Liability Com invested in 0% or 141 shares.

Analysts await SUPERVALU Inc. (NYSE:SVU) to report earnings on April, 24. They expect $0.77 earnings per share, down 15.38% or $0.14 from last year’s $0.91 per share. SVU’s profit will be $29.57 million for 4.97 P/E if the $0.77 EPS becomes a reality. After $0.61 actual earnings per share reported by SUPERVALU Inc. for the previous quarter, Wall Street now forecasts 26.23% EPS growth.

SUPERVALU INC., together with its subsidiaries, operates as a grocery wholesaler and retailer in the United States. The company has market cap of $588.04 million. The firm operates through two divisions, Wholesale and Retail. It has a 0.95 P/E ratio. The Wholesale segment engages in the wholesale distribution of various food and non-food products to independent retail customers, such as single and multiple grocery store operators, regional chains, and the military.

Hologic, Inc. (NASDAQ:HOLX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.